Mfg Part Number
Ab03842-1.1

Vector Labs Ab03842-1.1 Anti-Hendra and Nipah virus F [1F5], Mouse IgG1, kappa (100 μg)

Quick Overview
The original antibody was generated by immunizing mice with recombinant soluble constructs obtained from Nipah or Hendra virus.
$570.70
Order will ship within 1-3 business days
Add to Wish List
Product Class:Purified
Clone ID:1F5
Synonyms:NiV; HeV; NiV F; HeV F; Protein F; F protein; Fusion glycoprotein; Fusion glycoprotein F0; Hendra henipavirus; Nipah henipavirus
Amount:100 μg
Application Codes Clone:Functional assay; Neutralize
Shipping Temperature:Wet Ice
Buffer Composition:PBS with 0.02% Proclin 300.
Original Format:Fab
Storage Temperature:Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.
Chimeric Use Statement:This reformatted mouse antibody was made using the variable domain sequences of the original Mouse Fab format, for improved compatibility with existing reagents, assays and techniques.
Specificity Statement:This antibody binds a pre-fusion conformational epitope on the F glycoprotein of the Nipah and Hendra virus. The Nipah and Hendra virus are spread by bats.
Application Notes:This antibody is reported to broadly neutralize Nipah and Hendra virus by blocking membrane fusion. The cryogenic-electron microscopy (cryo-EM) structures of the antibody in complex with HeV F was determined. Biolayer interferometry was used to characterize the binding of the 1F5 Fab fragments to prefusion NiV F or HeV F ectodomain trimers immobilized on the surface of biosensors. The equilibrium dissociation constants (Kd) of 1.47 and 1.24 nM for attachment of Fab fragments of 1F5 to NiV F or HeV F, respectively. To further characterize this antibody, a kinetic assay was performed on HeV F- or NiV F- or NiV F S69A using the mouse version of this antibody. To analyze the ability of this antibody to prevent and cure disease, a fusion inhibition assay was performed on CHO745 cells transfected with HNV F and G glycoproteins using the mouse IgG version of this antibody. Further a plaque reduction assay was performed NiV-M, NiV-B or HeV using both the human and mouse IgG versions of this antibody. The humanized version of the antibody broadly inhibited NiV-M, NiV-B and HeV with IC50 ranging between 0.2 and 1.3 µg/ml (Dang et al., 2021; PMID:33927387).
More Information
Brand Vector Labs
UNSPSC 12161500